MedPath
FDA Approval

NORTRIPTYLINE HCI

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Direct_Rx
DUNS: 079254320
Effective Date
October 5, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Nortriptyline(25 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Direct_Rx

079254320

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Direct_Rx

Direct_Rx

Direct_Rx

079254320

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

NORTRIPTYLINE HCI

Product Details

NDC Product Code
61919-285
Application Number
ANDA075520
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
October 5, 2022
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3GClass: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
SHELLACInactive
Code: 46N107B71OClass: IACT
FD&C BLUE NO. 2Inactive
Code: L06K8R7DQKClass: IACT
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327LClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
ALUMINUM OXIDEInactive
Code: LMI26O6933Class: IACT
Code: 00FN6IH15DClass: ACTIMQuantity: 25 mg in 1 1
FD&C RED NO. 40Inactive
Code: WZB9127XOAClass: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357Class: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141JClass: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBDClass: IACT
© Copyright 2025. All Rights Reserved by MedPath